スーパーエイジャーにおけるアポリポタンパク質E遺伝子型と認知的レジリエンスの関連性の評価
Alaina Durant1, Shubhabrata Mukherjee2, Michael L Lee2
1Vanderbilt Memory & Alzheimer's Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 16, 2026
まとめ
若年のような記憶力を持つ80歳以上の人々であるスーパーエイジャーは、異なるアポリポタンパク質E(APOE)対立遺伝子パターンを示す。非ヒスパニック白人スーパーエイジャーはAPOE-ε4対立遺伝子が少なく、認知的レジリエンスにおける役割を示唆している。
科学分野:
- 神経科学
- 遺伝学
- 老化研究
背景:
- スーパーエイジャーとは、80歳以上の成人で、はるかに若い年齢層に匹敵する認知機能を持つ人々です。
- アポリポタンパク質E(APOE)対立遺伝子のような遺伝的要因を理解することは、認知的レジリエンスの研究にとって極めて重要です。
研究 の 目的:
- 非ヒスパニック白人(NHW)および非ヒスパニック黒人(NHB)集団におけるスーパーエイジャーとAPOE対立遺伝子頻度の関連を調査すること。
- スーパーエイジャーのAPOE対立遺伝子頻度を、対照群およびアルツハイマー病認知症患者と比較すること。
主な方法:
- 8つのコホートにわたる18,080人の参加者からのデータを分析しました。
- スーパーエイジャー、対照群、および患者を定義するために、標準化された臨床診断と認知評価(記憶、実行機能、言語)が使用されました。
- NHWおよびNHBスーパーエイジャーのAPOE対立遺伝子頻度を、対照群および疾患群と比較して検討しました。
主要な成果:
- NHWスーパーエイジャーは、すべての対照群および患者群と比較して、APOE-ε4対立遺伝子の頻度が有意に低く、APOE-ε2対立遺伝子の頻度が有意に高いことが示されました。
- NHBスーパーエイジャーでも同様の傾向が観察されましたが、サンプルサイズのため、すべての比較で統計的有意性に達しませんでした。
- これらの発見は、特定のAPOE対立遺伝子が加齢に伴う認知機能低下に対して保護的な役割を果たすことを示唆しています。
結論:
- APOE対立遺伝子頻度は、特にNHW集団において、スーパーエイジャーの状態と強く関連しています。
- 認知的レジリエンスメカニズムにおける人種間の潜在的な違いを解明するには、より大規模なNHBスーパーエイジャーコホートを用いたさらなる研究が必要です。
- この研究は、遺伝学と認知的加齢の間の複雑な相互作用を強調しています。
関連する概念動画
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Aging
612
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
612
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228


